RT Journal Article
T1 Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
A1 Strauss, S. J.
A1 Frezza, A. M.
A1 Abecassis, N.
A1 Bajpai, J.
A1 Bauer, S.
A1 Biagini, R.
A1 Bielack, S.
A1 Blay, J. Y.
A1 Bolle, S.
A1 Bonvalot, S.
A1 Boukovinas, I
A1 Bovee, J. V. M. G.
A1 Boye, K.
A1 Brennan, B.
A1 Brodowicz, T.
A1 Buonadonna, A.
A1 de-Alava, E.
A1 Dei-Tos, A. P.
A1 Del-Muro, X. Garcia
A1 Dufresne, A.
A1 Eriksson, M.
A1 Fagioli, F.
A1 Fedenko, A.
A1 Ferraresi, V
A1 Ferrari, A.
A1 Gaspar, N.
A1 Gasperoni, S.
A1 Gelderblom, H.
A1 Gouin, F.
A1 Grignani, G.
A1 Gronchi, A.
A1 Haas, R.
A1 Hassan, A. B.
A1 Hecker-Nolting, S.
A1 Hindi, N.
A1 Hohenberger, P.
A1 Joensuu, H.
A1 Jones, R. L.
A1 Jungels, C.
A1 Jutte, P.
A1 Kager, L.
A1 Kasper, B.
A1 Kawai, A.
A1 Kopeckova, K.
A1 Krakorova, D. A.
A1 Le-Cesne, A.
A1 Le-Grange, F.
A1 Legius, E.
A1 Leithner, A.
A1 Pousa, A. Lopez
A1 Martin-Broto, J.
A1 Merimsky, O.
A1 Messiou, C.
A1 Miah, A. B.
A1 Mir, O.
A1 Montemurro, M.
A1 Morland, B.
A1 Morosi, C.
A1 Palmerini, E.
A1 Pantaleo, M. A.
A1 Piana, R.
A1 Piperno-Neumann, S.
A1 Reichardt, P.
A1 Rutkowski, P.
A1 Safwat, A. A.
A1 Sangalli, C.
A1 Sbaraglia, M.
A1 Scheipl, S.
A1 Schoffski, P.
A1 Sleijfer, S.
A1 Strauss, D.
A1 Hall, K. Sundby
A1 Trama, A.
A1 Unk, M.
A1 van-de-Sande, M. A. J.
A1 van-der-Graaf, W. T. A.
A1 van-Houdt, W. J.
A1 Frebourg, T.
A1 Ladenstein, R.
A1 Casali, P. G.
A1 Stacchiotti, S.
K1 bone sarcoma
K1 clinical practice guideline
K1 diagnosis
K1 treatment
K1 follow-up
K1 management
K1 Localized ewing sarcoma
K1 Giant-cell tumor
K1 Malignant fibrous histiocytoma
K1 High-grade osteosarcoma
K1 High-dose ifosfamide
K1 Open-label
K1 Phase-ii
K1 Neoadjuvant chemotherapy
K1 Prognostic-factors
K1 Muramyl tripeptide
AB Primary bone sarcomas (BSs) account for <0.2% of malignant neoplasms across all ages.1 The overall incidence rate ranges between 0.8 and 0.9 cases per 100 000/year, with single BS types having no more than 0.3 incident cases per 100 000/year. Osteosarcoma and Ewing sarcoma (ES) have a relatively high incidence in the second decade of life, whereas conventional chondrosarcomas are more common in older age.2
PB Elsevier
SN 0923-7534
YR 2021
FD 2021-11-20
LK https://hdl.handle.net/10668/27443
UL https://hdl.handle.net/10668/27443
LA en
NO Strauss SJ, Frezza AM, Abecassis N, Bajpai J, Bauer S, Biagini R, et al. Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN  Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2021 Dec;32(12):1520-1536.
DS RISalud
RD Apr 11, 2025